Ophthalmic Executives Provide Company Updates (Part 1 of 2)
Listen now
Description
We hear from executives representing pharma and device manufacturers in the anterior segment who provide updates on their companies’ recently launched products and those in development. Learn more about your ad choices. Visit megaphone.fm/adchoices
More Episodes
The CEO of Lumithera joins us to discuss the FDA authorization of the Veleda system for dry AMD; the FDA accepts the resubmitted NDA for dry eye disease candidate reproxalap; and Alcon launches the first contact lens designed for a 1-week replacement cycle. Learn more about your ad choices. Visit...
Published 11/20/24
Published 11/20/24
Leaders of several ophthalmic companies with a focus on the posterior segment provide updates on their pipeline and new products in this special edition of EyewireTV. Learn more about your ad choices. Visit megaphone.fm/adchoices
Published 11/13/24